Microbial adhesion of Cryptosporidium parvum: Identification of a colostrum-derived inhibitory lipid

Molecular and Biochemical Parasitology

Volumn 162, Issue 1, 2008, Pages 32-39

  Schmidt, Joann ^a   Kuhlenschmidt, Mark S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Adhesion; Colostrum; Cryptosporidium parvum; Fatty acid; Invasion; Oleic acid; Sporozoites

Indexed keywords

LIPID; LONG CHAIN FATTY ACID; OLEIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; STEARIC ACID; TRIACYLGLYCEROL;

ARTICLE; CALF (BOVINE); CELL ADHESION; CELL VIABILITY; COLOSTRUM; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; DOSE RESPONSE; IC 50; IN VITRO STUDY; INCUBATION TIME; INTESTINE MUCOSA; MASS SPECTROMETRY; MICROBIAL ADHESION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPOROZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; CATTLE; CELL ADHESION; CELL LINE; CHROMATOGRAPHY, GAS; COLOSTRUM; CRYPTOSPORIDIUM PARVUM; HOST-PARASITE INTERACTIONS; INTESTINAL MUCOSA; MAGNETIC RESONANCE SPECTROSCOPY; OLEIC ACID; PARASITIC SENSITIVITY TESTS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPOROZOITES;

BOVINAE; CRYPTOSPORIDIUM PARVUM;

EID: 52049121506     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2008.06.016     Document Type: Article

References (39)

1. Hill V.R., Kahler A.M., Jothikumar N., Johnson T.B., Hahn D., and Cromeans T.L. Multistate evaluation of an ultrafiltration-based procedure for simultaneous recovery of enteric microbes in 100-liter tap water samples. Appl Environ Microbiol 73 (2007) 4218-4225
2. Ruecker N.J., Braithwaite S.L., Topp E., et al. Tracking host sources of Cryptosporidium spp. in raw water for improved health risk assessment. Appl Environ Microbiol 73 (2007) 3945-3957
3. Molloy S.L., Montgomery A.E., Huffman D.E., and Rose J.B. Detection of Cryptosporidium parvum oocysts in sediment and biosolids by immunomagnetic separation. Water Environ Res 78 (2006) 1013-1016
4. Ochiai Y., Takada C., and Hosaka M. Detection and discrimination of Cryptosporidium parvum and C. hominis in water samples by immunomagnetic separation-PCR. Appl Environ Microbiol 71 (2005) 898-903
5. Schets F.M., Engels G.B., During M., and de Roda Husman A.M. Detection of infectious Cryptosporidium oocysts by cell culture immunofluorescence assay: applicability to environmental samples. Appl Environ Microbiol 71 (2005) 6793-6798
6. Jiang J., Alderisio K.A., Singh A., and Xiao L. Development of procedures for direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR inhibitors. Appl Environ Microbiol 71 (2005) 1135-1141
7. Thurston-Enriquez J.A., Gilley J.E., and Eghball B. Microbial quality of runoff following land application of cattle manure and swine slurry. J Water Health 3 (2005) 157-171
8. Simmons III O.D., and Sobsey M.D. A chemiluminescent immunofocus assay (CIFA) for non-microscopic enumeration of Cryptosporidium parvum infectivity in cell culture. Water Sci Technol 47 (2003) 137-142
9. Coulliette A.D., Huffman D.E., Slifko T.R., and Rose J.B. Cryptosporidium parvum: treatment effects and the rate of decline in oocyst infectivity. J Parasitol 92 (2006) 58-62
10. Hunter P.R., Hadfield S.J., Wilkinson D., Lake I.R., Harrison F.C., and Chalmers R.M. Subtypes of Cryptosporidium parvum in humans and disease risk. Emerg Infect Dis 13 (2007) 82-88
11. Anderson V.R., and Curran M.P. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs 67 (2007) 1947-1967
12. Graczyk T.K., Cranfield M.R., and Bostwick E.F. Successful hyperimmune bovine colostrum treatment of Savanna monitors (Varanus exanthematicus) infected with Cryptosporidium sp. J Parasitol 86 (2000) 631-632
13. Graczyk T.K., Cranfield M.R., and Bostwick E.F. Hyperimmune bovine colostrum treatment of moribund Leopard geckos (Eublepharis macularius) infected with Cryptosporidium sp. Vet Res 30 (1999) 377-382
14. Graczyk T.K., Cranfield M.R., Helmer P., Fayer R., and Bostwick E.F. Therapeutic efficacy of hyperimmune bovine colostrum treatment against clinical and subclinical Cryptosporidium serpentis infections in captive snakes. Vet Parasitol 74 (1998) 123-132
15. Fayer R., Guidry A., and Blagburn B.L. Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infect Immun 58 (1990) 2962-2965
16. Fayer R., Andrews C., Ungar B.L., and Blagburn B. Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. J Parasitol 75 (1989) 393-397
17. Perryman L.E., Kapil S.J., Jones M.L., and Hunt E.L. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. Vaccine 17 (1999) 2142-2149
18. Naciri M., Mancassola R., Reperant J.M., Canivez O., Quinque B., and Yvore P. Treatment of experimental ovine cryptosporidiosis with ovine or bovine hyperimmune colostrum. Vet Parasitol 53 (1994) 173-190
19. Riggs M.W., Cama V.A., Leary Jr. H.L., and Sterling C.R. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect Immun 62 (1994) 1927-1939
20. Watzl B., Huang D.S., Alak J., Darban H., Jenkins E.M., and Watson R.R. Enhancement of resistance to Cryptosporidium parvum by pooled bovine colostrum during murine retroviral infection. Am J Trop Med Hyg 48 (1993) 519-523
21. Nord J., Ma P., DiJohn D., Tzipori S., and Tacket C.O. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. Aids 4 (1990) 581-584
22. Shield J., Melville C., Novelli V., et al. Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS. Arch Dis Child 69 (1993) 451-453
23. Greenberg P.D., and Cello J.P. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13 (1996) 348-354
24. Ungar B.L., Ward D.J., Fayer R., and Quinn C.A. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology 98 (1990) 486-489
25. Floren C.H., Chinenye S., Elfstrand L., Hagman C., and Ihse I. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand J Gastroenterol 41 (2006) 682-686
26. Flanigan T., Marshall R., Redman D., Kaetzel C., and Ungar B. In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory. J Protozool 38 (1991) 225S-227S
27. Johnson J.K., Schmidt J., Gelberg H.B., and Kuhlenschmidt M.S. Microbial adhesion of Cryptosporidium parvum sporozoites: purification of an inhibitory lipid from bovine mucosa. J Parasitol 90 (2004) 980-990
28. Current W.L. Techniques and laboratory maintenance of Cryptosporidium. In: Dubey J.P., Speer C.A., and Fayer R. (Eds). Cryptosporidiosis of man and animals (1990), CRC Press, Boca Raton, FL 31-49
29. Fenselau C., and Cotter R.J. Chemical aspects of fast atom bombardment. Chem Rev 87 (1987) 501-512
30. Thormar H., Isaacs C.E., Brown H.R., Barshatzky M.R., and Pessolano T. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31 (1987) 27-31
31. Hernell O., Ward H., Blackberg L., and Pereira M.E. Killing of Giardia lamblia by human milk lipases: an effect mediated by lipolysis of milk lipids. J Infect Dis 153 (1986) 715-720
32. Clegg R.A. Activation of milk lipase by serum proteins: possible role in the occurrence of lipolysis in raw bovine milk. J Dairy Res 47 (1980) 61-70
33. Coskun H., and Ondul E. Free fatty acid accumulation by mesophilic lactic acid bacteria in cold-stored milk. J Microbiol 42 (2004) 133-138
34. Mansbridge R.J., and Blake J.S. Nutritional factors affecting the fatty acid composition of bovine milk. Br J Nutr 78 Suppl 1 (1997) S37-47
35. Krugliak M., Deharo E., Shalmiev G., Sauvain M., Moretti C., and Ginsburg H. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo. Exp Parasitol 81 (1995) 97-105
36. Reiner D.S., Wang C.S., and Gillin F.D. Human milk kills Giardia lamblia by generating toxic lipolytic products. J Infect Dis 154 (1986) 825-832
37. Zenian A.J., and Gillin F.D. Intestinal mucus protects Giardia lamblia from killing by human milk. J Protozool 34 (1987) 22-26
38. Wetzel D.M., Schmidt J., Kuhlenschmidt M.S., Dubey J.P., and Sibley L.D. Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites. Infect Immun 73 (2005) 5379-5387
39. Sibley L.D. Intracellular parasite invasion strategies. Science 304 (2004) 248-253